Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

N Galldiks, M Rapp, G Stoffels, GR Fink… - European journal of …, 2013 - Springer
Purpose To investigate prospectively the potential of O-(2-[18 F] fluoroethyl)-l-tyrosine (18 F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …
被引用次数：193 相关文章

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F] Fluoroethyl-L-tyrosine PET in comparison to MRI.

N Galldiks, M Rapp, G Stoffels, GR Fink… - European Journal of …, 2012 - europepmc.org
Purpose To investigate prospectively the potential of O-(2-[(18) F] fluoroethyl)-L-tyrosine
((18) F-FET) PET in comparison to MRI for the assessment of the response of patients with …

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

N Galldiks, GR Fink, M Rapp, M Sabel… - European Journal of …, 2013 - inis.iaea.org
[en] To investigate prospectively the potential of O-(2-[18 F] fluoroethyl)-l-tyrosine (18 F-FET)
PET in comparison to MRI for the assessment of the response of patients with recurrent high …
[PDF] researchgate.net

[PDF][PDF] Response assessment of bevacizumab in patients with recurrent malignant glioma using [18 F] Fluoroethyl-L-tyrosine PET in comparison to MRI

N Galldiks, M Rapp, G Stoffels, GR Fink… - Eur J Nucl Med Mol …, 2013 - researchgate.net
Purpose To investigate prospectively the potential of O-(2-[18F] fluoroethyl)-L-tyrosine (18F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …

Response assessment of bevacizumab in patients with recurrent malignant glioma using [F] Fluoroethyl-l-tyrosine PET in comparison to MRI.

N Galldiks, M Rapp, G Stoffels, G Fink… - … Journal of Nuclear …, 2013 - search.ebscohost.com
Purpose: To investigate prospectively the potential of O-(2-[F] fluoroethyl)-l-tyrosine (F-FET)
PET in comparison to MRI for the assessment of the response of patients with recurrent high …

[引用][C] Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F] Fluoroethyl-l-tyrosine PET in comparison to MRI

N Galldiks, M Rapp, G Stoffels, GR Fink… - European Journal of …, 2012 - cir.nii.ac.jp
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine
PET in comparison to MRI | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F] Fluoroethyl-l-tyrosine PET in comparison to MRI

N Galldiks, M Rapp, G Stoffels, GR Fink… - European Journal of …, 2013 - infona.pl
Purpose To investigate prospectively the potential of O-(2-[18F] fluoroethyl)-l-tyrosine (18F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …

Response assessment of bevacizumab in patients with recurrent malignant glioma using [^ sup 18^ F] Fluoroethyl-l-tyrosine PET in comparison to MRI

N Galldiks, M Rapp, G Stoffels, GR Fink… - … Journal of Nuclear …, 2013 - search.proquest.com
Response assessment of bevacizumab in patients with recurrent malignant glioma using [ F]
Fluoroethyl-L-tyrosine PET in comparis Page 1 ORIGINAL ARTICLE Response assessment of …

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F] Fluoroethyl-L-tyrosine PET in comparison to MRI

N Galldiks, M Rapp, G Stoffels… - … journal of nuclear …, 2013 - pubmed.ncbi.nlm.nih.gov
Purpose To investigate prospectively the potential of O-(2-[(18) F] fluoroethyl)-L-tyrosine
((18) F-FET) PET in comparison to MRI for the assessment of the response of patients with …
[HTML] osti.gov

[HTML][HTML] Response assessment of bevacizumab in patients with recurrent malignant glioma using [{sup 18} F] Fluoroethyl-l-tyrosine PET in comparison to MRI

N Galldiks, GR Fink, M Rapp, M Sabel, G Stoffels… - European Journal of …, 2013 - osti.gov
To investigate prospectively the potential of O-(2-[{sup 18} F] fluoroethyl)-l-tyrosine ({sup 18}
F-FET) PET in comparison to MRI for the assessment of the response of patients with …